ACAD logo

ACADIA Pharmaceuticals (ACAD) Total Assets

Annual Total Assets

$1.19 B
+$438.80 M+58.59%

December 31, 2024


Summary


Performance

ACAD Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Quarterly Total Assets

$1.19 B
+$210.89 M+21.59%

December 31, 2024


Summary


Performance

ACAD Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

ACAD Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+58.6%+58.6%
3 y3 years+69.7%+69.7%
5 y5 years+51.7%+51.7%

ACAD Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+102.1%at high+102.1%
5 y5-yearat high+102.1%at high+102.1%
alltimeall timeat high+7312.7%at high+5330.0%

ACADIA Pharmaceuticals Total Assets History

DateAnnualQuarterly
Dec 2024
$1.19 B(+58.6%)
$1.19 B(+21.6%)
Sep 2024
-
$976.87 M(+6.9%)
Jun 2024
-
$914.10 M(+6.9%)
Mar 2024
-
$855.10 M(+14.2%)
Dec 2023
$748.96 M(+27.4%)
$748.96 M(+18.4%)
Sep 2023
-
$632.54 M(-1.6%)
Jun 2023
-
$642.77 M(-1.9%)
Mar 2023
-
$655.30 M(+11.5%)
Dec 2022
$587.81 M(-16.0%)
$587.81 M(-2.4%)
Sep 2022
-
$602.49 M(-1.7%)
Jun 2022
-
$612.77 M(-1.8%)
Mar 2022
-
$624.25 M(-10.8%)
Dec 2021
$700.12 M(-10.5%)
$700.12 M(-2.4%)
Sep 2021
-
$717.67 M(-0.9%)
Jun 2021
-
$724.43 M(-4.1%)
Mar 2021
-
$755.17 M(-3.5%)
Dec 2020
$782.62 M(-0.1%)
$782.62 M(-1.6%)
Sep 2020
-
$795.66 M(+4.7%)
Jun 2020
-
$759.65 M(+1.6%)
Mar 2020
-
$747.45 M(-4.6%)
Dec 2019
$783.18 M(+45.0%)
$783.18 M(+2.3%)
Sep 2019
-
$765.59 M(+66.1%)
Jun 2019
-
$460.88 M(-8.0%)
Mar 2019
-
$501.11 M(-7.2%)
Dec 2018
$540.20 M(+40.5%)
$540.20 M(+102.7%)
Sep 2018
-
$266.46 M(-15.4%)
Jun 2018
-
$314.96 M(-10.3%)
Mar 2018
-
$351.04 M(-8.7%)
Dec 2017
$384.51 M(-31.5%)
$384.51 M(-7.1%)
Sep 2017
-
$413.71 M(-9.3%)
Jun 2017
-
$456.31 M(-9.3%)
Mar 2017
-
$503.01 M(-10.4%)
Dec 2016
$561.15 M(+152.9%)
$561.15 M(-9.1%)
Sep 2016
-
$617.38 M(+40.9%)
Jun 2016
-
$438.03 M(-6.1%)
Mar 2016
-
$466.59 M(+110.3%)
Dec 2015
$221.90 M(-31.8%)
$221.90 M(-9.5%)
Sep 2015
-
$245.32 M(-11.0%)
Jun 2015
-
$275.54 M(-8.8%)
Mar 2015
-
$301.96 M(-7.2%)
Dec 2014
$325.46 M(+72.1%)
$325.46 M(-4.8%)
Sep 2014
-
$341.76 M(-4.9%)
Jun 2014
-
$359.46 M(-3.8%)
Mar 2014
-
$373.51 M(+97.5%)
DateAnnualQuarterly
Dec 2013
$189.12 M(+74.2%)
$189.12 M(-5.1%)
Sep 2013
-
$199.28 M(-3.7%)
Jun 2013
-
$206.91 M(+100.9%)
Mar 2013
-
$103.02 M(-5.1%)
Dec 2012
$108.59 M(+238.1%)
$108.59 M(+357.2%)
Sep 2012
-
$23.75 M(+8.6%)
Jun 2012
-
$21.87 M(-17.5%)
Mar 2012
-
$26.52 M(-17.4%)
Dec 2011
$32.11 M(-16.4%)
$32.11 M(-13.3%)
Sep 2011
-
$37.02 M(-10.4%)
Jun 2011
-
$41.31 M(-11.9%)
Mar 2011
-
$46.89 M(+22.1%)
Dec 2010
$38.39 M(-22.7%)
$38.39 M(+7.4%)
Sep 2010
-
$35.75 M(-8.7%)
Jun 2010
-
$39.17 M(-9.5%)
Mar 2010
-
$43.27 M(-12.9%)
Dec 2009
$49.68 M(-23.2%)
$49.68 M(-15.0%)
Sep 2009
-
$58.48 M(-16.5%)
Jun 2009
-
$70.06 M(+39.1%)
Mar 2009
-
$50.37 M(-22.1%)
Dec 2008
$64.68 M(-51.9%)
$64.68 M(-17.3%)
Sep 2008
-
$78.20 M(-18.6%)
Jun 2008
-
$96.08 M(-15.2%)
Mar 2008
-
$113.33 M(-15.8%)
Dec 2007
$134.58 M(+50.3%)
$134.58 M(-9.3%)
Sep 2007
-
$148.35 M(-7.4%)
Jun 2007
-
$160.22 M(+111.5%)
Mar 2007
-
$75.75 M(-15.4%)
Dec 2006
$89.54 M(+43.3%)
$89.54 M(-11.3%)
Sep 2006
-
$100.91 M(-12.7%)
Jun 2006
-
$115.57 M(+81.9%)
Mar 2006
-
$63.52 M(+1.6%)
Dec 2005
$62.51 M(+54.9%)
$62.51 M(-11.0%)
Sep 2005
-
$70.27 M(-4.6%)
Jun 2005
-
$73.63 M(+60.3%)
Mar 2005
-
$45.92 M(+13.8%)
Dec 2004
$40.37 M(+27.4%)
$40.37 M(-15.5%)
Sep 2004
-
$47.75 M(-10.4%)
Jun 2004
-
$53.30 M(+94.4%)
Mar 2004
-
$27.42 M(-13.5%)
Dec 2003
$31.69 M(+97.8%)
$31.69 M
Dec 2002
$16.02 M(-27.0%)
-
Dec 2001
$21.96 M(-35.6%)
-
Dec 2000
$34.11 M
-

FAQ

  • What is ACADIA Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual total assets year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly total assets year-on-year change?

What is ACADIA Pharmaceuticals annual total assets?

The current annual total assets of ACAD is $1.19 B

What is the all time high annual total assets for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual total assets is $1.19 B

What is ACADIA Pharmaceuticals annual total assets year-on-year change?

Over the past year, ACAD annual total assets has changed by +$438.80 M (+58.59%)

What is ACADIA Pharmaceuticals quarterly total assets?

The current quarterly total assets of ACAD is $1.19 B

What is the all time high quarterly total assets for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly total assets is $1.19 B

What is ACADIA Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, ACAD quarterly total assets has changed by +$438.80 M (+58.59%)